National Geographic’s recent investigation into NAD+ supplementation has revealed a disconnect between the booming market for these anti-aging products and the scientific evidence supporting their effectiveness. While NAD+ (nicotinamide adenine dinucleotide) is a crucial molecule involved in cellular energy production and DNA repair, experts remain skeptical about whether oral supplements can deliver meaningful longevity benefits.
NAD+ levels naturally decline with age, dropping by as much as 50% between youth and middle age. This observation has fueled a supplement industry worth hundreds of millions of dollars, with companies marketing NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) as potential fountain-of-youth compounds. However, researchers interviewed by National Geographic emphasized that most evidence comes from animal studies, with human clinical trials showing mixed results at best.
The primary challenge lies in bioavailability. According to the experts consulted, it remains unclear whether these supplements can effectively raise NAD+ levels in human tissues where it matters most—particularly in organs like the brain and heart. While some small studies have shown increases in blood NAD+ levels, whether this translates to actual cellular benefits or extended lifespan in humans is unproven.
For consumers considering NAD+ supplements, the message is one of caution. These products can cost upwards of $50-100 per month, yet lack the robust clinical evidence typically required to support health claims. Experts suggest that proven interventions like regular exercise and caloric restriction remain the most reliable methods to maintain cellular NAD+ levels naturally. Until larger, long-term human trials are completed, the promise of NAD+ supplementation for longevity remains largely theoretical rather than evidence-based.
